EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Application and Research Advancement of Antibody-Conjugated Drugs in Non-Small Cell Lung Cancer

Binting Huang, Kaifang Li, Xiangsheng Wu, Fuyi Zhang, Yepeng Li

Journal of Biosciences and Medicines · 2025 · 13 (01) · 145-162

DOI: 10.4236/jbm.2025.131012 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Biosciences and Medicines, 2025. Verfasst von Binting Huang und 4 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lung cancer is one of the malignant tumor diseases with high morbidity and high mortality in the world. Non-small cell lung cancer (NSCLC) is the most common pathological type of lung cancer. Currently, chemotherapy, targeted therapy, immunotherapy or combination therapy is the main treatment for NSCLC, but it is still inevitably faced with the challenges of acquired drug resistance and tumor progression. The birth of antibody conjugator provides a new choice for its treatment. Antibody conjugator is a new type of biotherapeutic drug which is connected by monoclonal antibody via linker and cytotoxic drug. It has the characteristics of precision, high efficiency and low toxicity, etc. In recent years, its research and development and clinical trials have been endless. It shows that this new type of drug has great potential in the field of tumor therapy. In this paper, the structural characteristics, mechanism of action, current application, research achievements, challenges, countermeasures and development of ADC in NSCLC treatment are reviewed.

Zitieren

APA

Huang, B., Li, K., Wu, X., Zhang, F., & Li, Y. (2025). Application and Research Advancement of Antibody-Conjugated Drugs in Non-Small Cell Lung Cancer. Journal of Biosciences and Medicines, 13(01), 145-162. https://doi.org/10.4236/jbm.2025.131012

Vancouver

Huang B, Li K, Wu X, Zhang F, Li Y. Application and Research Advancement of Antibody-Conjugated Drugs in Non-Small Cell Lung Cancer. Journal of Biosciences and Medicines. 2025;13(01):145-162. doi:10.4236/jbm.2025.131012

BibTeX
@article{Huang2025,
  author = {Huang, Binting and Li, Kaifang and Wu, Xiangsheng and Zhang, Fuyi and Li, Yepeng},
  title = {Application and Research Advancement of Antibody-Conjugated Drugs in Non-Small Cell Lung Cancer},
  journal = {Journal of Biosciences and Medicines},
  year = {2025},
  volume = {13},
  number = {01},
  pages = {145--162},
  doi = {10.4236/jbm.2025.131012}
}
Kostenlos starten →